Advertisement
Screener

CASTLE BIOSCIENCES, INC. (CSTL) Amortization of Intangible Assets

2.8 / 5 stars · 68/120 Roast Me

CASTLE BIOSCIENCES, INC. Amortization of Intangible Assets

CASTLE BIOSCIENCES, INC. (CSTL) reported Amortization of Intangible Assets of $2.25 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2026-07-30

  • CASTLE BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2026-06-30 was $2.25M, a 14.79% increase year-over-year.
  • CASTLE BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2026-03-31 was $2.23M, a 92.14% decline year-over-year.
  • CASTLE BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2025-12-31 was $2.28M, a 47.56% decline year-over-year.
  • CASTLE BIOSCIENCES, INC. amortization of intangible assets for the quarter ending 2025-09-30 was $2.28M, a 0.18% increase year-over-year.
  • CASTLE BIOSCIENCES, INC. amortization of intangible assets for fiscal 2025 was $34.84M, a 213.69% increase from fiscal 2024.
  • CASTLE BIOSCIENCES, INC. amortization of intangible assets for fiscal 2024 was $11.11M, a 23.22% increase from fiscal 2023.
  • CASTLE BIOSCIENCES, INC. amortization of intangible assets for fiscal 2023 was $9.01M, a 9.04% increase from fiscal 2022.
  • CASTLE BIOSCIENCES, INC. amortization of intangible assets for fiscal 2022 was $8.27M, a 322.17% increase from fiscal 2021.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 6 month as first filedAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 9 month as first filedAmortization of Intangible Assets 12 month
2026-06-30$2.25M
10-Q · filed 2026-07-30
$4.48M
10-Q · filed 2026-07-30
$6.75M
derived: sum of 3 quarters · filed 2026-07-30
$9.03M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$2.23M
10-Q · filed 2026-05-06
$4.50M
derived: sum of 2 quarters · filed 2026-05-06
$6.78M
derived: sum of 3 quarters · filed 2026-05-06
$8.74M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$2.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$4.55M
derived: sum of 2 quarters · filed 2026-02-26
$6.51M
derived: sum of 3 quarters · filed 2026-07-30
$34.84M
10-K · filed 2026-02-26
2025-09-30$2.28M
10-Q · filed 2025-11-03
$4.24M
derived: sum of 2 quarters · filed 2026-07-30
$32.56M
10-Q · filed 2025-11-03
$36.90M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$1.96M
10-Q · filed 2026-07-30
$30.29M
10-Q · filed 2026-07-30
$34.63M
derived: sum of 3 quarters · filed 2026-07-30
$36.90M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$28.32M
10-Q · filed 2026-05-06
$32.66M
derived: sum of 2 quarters · filed 2026-05-06
$34.94M
derived: sum of 3 quarters · filed 2026-05-06
$37.18M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31$4.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$6.61M
derived: sum of 2 quarters · filed 2026-02-26
$8.86M
derived: sum of 3 quarters · filed 2026-02-26
$11.11M
10-K · filed 2026-02-26
2024-09-30$2.27M
10-Q · filed 2025-11-03
$4.52M
derived: sum of 2 quarters · filed 2025-11-03
$6.77M
10-Q · filed 2025-11-03
$9.04M
derived: sum of 4 quarters · filed 2026-02-26
2024-06-30$2.25M
10-Q · filed 2025-08-04
$4.49M
10-Q · filed 2025-08-04
$6.76M
derived: sum of 3 quarters · filed 2026-02-26
$9.04M
derived: sum of 4 quarters · filed 2026-02-26
2024-03-31$2.25M
10-Q · filed 2025-05-05
$4.52M
derived: sum of 2 quarters · filed 2026-02-26
$6.79M
derived: sum of 3 quarters · filed 2026-02-26
$9.04M
derived: sum of 4 quarters · filed 2026-02-26
2023-12-31$2.27M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
$4.54M
derived: sum of 2 quarters · filed 2026-02-26
$6.79M
derived: sum of 3 quarters · filed 2026-02-26
$9.01M
10-K · filed 2026-02-26
2023-09-30$2.27M
10-Q · filed 2024-11-04
$4.52M
derived: sum of 2 quarters · filed 2024-11-04
$6.74M
10-Q · filed 2024-11-04
$8.96M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$2.25M
10-Q · filed 2024-08-05
$4.47M
10-Q · filed 2024-08-05
$6.68M
derived: sum of 3 quarters · filed 2025-02-27
$8.99M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$2.22M
10-Q · filed 2024-05-02
$4.44M
derived: sum of 2 quarters · filed 2025-02-27
$6.74M
derived: sum of 3 quarters · filed 2025-02-27
$8.84M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$2.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$4.52M
derived: sum of 2 quarters · filed 2025-02-27
$6.62M
derived: sum of 3 quarters · filed 2025-02-27
$8.27M
10-K · filed 2025-02-27
2022-09-30$2.31M
10-Q · filed 2023-11-02
$4.40M
derived: sum of 2 quarters · filed 2023-11-02
$6.05M
10-Q · filed 2023-11-02
$7.06M
derived: sum of 4 quarters · filed 2023-11-02
2022-06-30$2.10M
10-Q · filed 2023-08-02
$3.75M
10-Q · filed 2023-08-02
$4.75M
derived: sum of 3 quarters · filed 2023-08-02
$5.45M
derived: sum of 4 quarters · filed 2023-08-02
2022-03-31$1.65M
10-Q · filed 2023-05-03
$2.66M
derived: sum of 2 quarters · filed 2023-05-03
$3.35M
derived: sum of 3 quarters · filed 2023-05-03
$3.61M
derived: sum of 4 quarters · filed 2023-05-03
2021-12-31$1.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$1.70M
derived: sum of 2 quarters · filed 2023-02-28
$1.96M
derived: sum of 3 quarters · filed 2023-02-28
$1.96M
10-K · filed 2023-02-28
2021-09-30$694.00K
10-Q · filed 2022-11-02
$950.00K
derived: sum of 2 quarters · filed 2022-11-02
$950.00K
10-Q · filed 2022-11-02
$950.00K
derived: sum of 4 quarters · filed 2022-11-02
2021-06-30$256.00K
10-Q · filed 2022-08-08
$256.00K
10-Q · filed 2022-08-08
$256.00K
derived: sum of 3 quarters · filed 2022-08-08
$256.00K
derived: sum of 4 quarters · filed 2022-08-08
2021-03-31$0.00
10-Q · filed 2022-05-09
$0.00
derived: sum of 2 quarters · filed 2022-05-09
$0.00
derived: sum of 3 quarters · filed 2022-05-09
$0.00
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$0.00
derived: sum of 2 quarters · filed 2022-02-28
$0.00
derived: sum of 3 quarters · filed 2022-02-28
$0.00
10-K · filed 2022-02-28
2020-09-30$0.00
10-Q · filed 2021-11-08
$0.00
derived: sum of 2 quarters · filed 2021-11-08
$0.00
10-Q · filed 2021-11-08
$0.00
derived: sum of 4 quarters · filed 2021-11-08
2020-06-30$0.00
10-Q · filed 2021-08-09
$0.00
10-Q · filed 2021-08-09
$0.00
derived: sum of 3 quarters · filed 2021-08-09
$0.00
derived: sum of 4 quarters · filed 2021-08-09
2020-03-31$0.00
10-Q · filed 2020-05-11
$0.00
derived: sum of 2 quarters · filed 2021-03-11
$0.00
derived: sum of 3 quarters · filed 2021-03-11
$1.67K
derived: sum of 4 quarters · filed 2021-03-11
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$0.00
derived: sum of 2 quarters · filed 2021-03-11
$1.67K
derived: sum of 3 quarters · filed 2021-03-11
$4.00K
10-K · filed 2021-03-11
2019-09-30$0.00
10-Q · filed 2019-11-12
$1.67K
derived: sum of 2 quarters · filed 2019-11-12
$4.00K
10-Q · filed 2020-11-09
$4.17K
10-Q · filed 2019-11-12
$13.21K
derived: sum of 4 quarters · filed 2020-05-11
2019-06-30$1.67K
10-Q · filed 2019-09-03
$4.00K
10-Q · filed 2020-08-10
$4.17K
10-Q · filed 2019-09-03
$13.21K
derived: sum of 3 quarters · filed 2020-05-11
$21.99K
derived: sum of 4 quarters · filed 2020-05-11
2019-03-31$3.00K
10-Q · filed 2020-05-11
$11.55K
derived: sum of 2 quarters · filed 2020-05-11
$20.33K
derived: sum of 3 quarters · filed 2020-05-11
$29.66K
derived: sum of 4 quarters · filed 2020-05-11
2018-12-31$8.55K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10
$17.33K
derived: sum of 2 quarters · filed 2020-03-10
$26.66K
derived: sum of 3 quarters · filed 2020-03-10
$36.00K
10-K · filed 2020-03-10
2018-09-30$8.78K
10-Q · filed 2019-11-12
$18.11K
derived: sum of 2 quarters · filed 2019-11-12
$27.45K
10-Q · filed 2019-11-12
2018-06-30$9.34K
10-Q · filed 2019-09-03
$18.67K
10-Q · filed 2019-09-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Personalis, Inc. (PSNL)United States$1.769B-13.30
BIODESIX INC (BDSX)United States$0.312B
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
EXAGEN INC. (XGN)United States$0.212B-5.95
Freenome, Inc. (FRNM)United States$0.143B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B